Global Non-Invasive Prenatal DNA Testing Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

April 2026 | 109 pages | ID: G874548B90F3EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Non-Invasive Prenatal DNA Testing Service market size was valued at US$ 760 million in 2025 and is forecast to a readjusted size of US$ 1563 million by 2032 with a CAGR of 10.9% during review period.

Non-Invasive Prenatal DNA Testing Service refers to a clinical service in which fetal genetic risk is assessed through the analysis of DNA signals obtained from a pregnant individual without the need for invasive sampling procedures. The service typically involves standardized sample collection, laboratory analysis, bioinformatic interpretation, and structured clinical reporting, with results used to inform follow-up testing and prenatal care decisions. It is delivered through centralized or networked laboratories as an integrated service offering rather than a standalone product, and its value lies in providing safe, accessible, and clinically actionable genetic information within established prenatal care pathways.

The Non-Invasive Prenatal DNA Testing Service market is positioned as a cornerstone of contemporary prenatal care delivery, driven by its ability to combine patient safety with scalable, high-throughput risk assessment. Market evolution is characterized by a steady shift from product-centric testing toward service-oriented models that emphasize clinical reliability, operational efficiency, and integration into standardized obstetric workflows. Competitive differentiation increasingly hinges on analytical performance in challenging samples, consistency across large testing volumes, turnaround reliability, and the quality of clinical support provided to physicians and patients, including reporting clarity and genetic counseling pathways. At the same time, regulatory oversight and reimbursement frameworks continue to shape adoption patterns, favoring providers that can demonstrate robust quality systems, transparent limitations, and dependable end-to-end execution across healthcare networks.

This report is a detailed and comprehensive analysis for global Non-Invasive Prenatal DNA Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Non-Invasive Prenatal DNA Testing Service market size and forecasts, in consumption value ($ Million), 2021-2032

Global Non-Invasive Prenatal DNA Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Non-Invasive Prenatal DNA Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Non-Invasive Prenatal DNA Testing Service market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:
  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Non-Invasive Prenatal DNA Testing Service
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Prenatal DNA Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Myriad Genetics, GGA, Fulgent Genetics, BillionToOne, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Non-Invasive Prenatal DNA Testing Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Core Condition Screening
  • Expanded Condition Screening
Market segment by Sequencing Method
  • Whole Genome Sequencing
  • Targeted Sequencing
  • Others
Market segment by Service Model
  • Public Health Program
  • Consumer
  • Others
Market segment by Application
  • Public Hospitals
  • Private Hospitals
Market segment by players, this report covers
  • Natera
  • Labcorp
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • SYNLAB
  • Myriad Genetics
  • GGA
  • Fulgent Genetics
  • BillionToOne
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Genesky
  • Weihansi Biomedical Technology
Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Non-Invasive Prenatal DNA Testing Service product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Non-Invasive Prenatal DNA Testing Service, with revenue, gross margin, and global market share of Non-Invasive Prenatal DNA Testing Service from 2021 to 2026.

Chapter 3, the Non-Invasive Prenatal DNA Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Prenatal DNA Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Prenatal DNA Testing Service.

Chapter 13, to describe Non-Invasive Prenatal DNA Testing Service research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Invasive Prenatal DNA Testing Service by Type
  1.3.1 Overview: Global Non-Invasive Prenatal DNA Testing Service Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type in 2025
  1.3.3 Core Condition Screening
  1.3.4 Expanded Condition Screening
1.4 Classification of Non-Invasive Prenatal DNA Testing Service by Sequencing Method
  1.4.1 Overview: Global Non-Invasive Prenatal DNA Testing Service Market Size by Sequencing Method: 2021 Versus 2025 Versus 2032
  1.4.2 Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Sequencing Method in 2025
  1.4.3 Whole Genome Sequencing
  1.4.4 Targeted Sequencing
  1.4.5 Others
1.5 Classification of Non-Invasive Prenatal DNA Testing Service by Service Model
  1.5.1 Overview: Global Non-Invasive Prenatal DNA Testing Service Market Size by Service Model: 2021 Versus 2025 Versus 2032
  1.5.2 Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Service Model in 2025
  1.5.3 Public Health Program
  1.5.4 Consumer
  1.5.5 Others
1.6 Global Non-Invasive Prenatal DNA Testing Service Market by Application
  1.6.1 Overview: Global Non-Invasive Prenatal DNA Testing Service Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Public Hospitals
  1.6.3 Private Hospitals
1.7 Global Non-Invasive Prenatal DNA Testing Service Market Size & Forecast
1.8 Global Non-Invasive Prenatal DNA Testing Service Market Size and Forecast by Region
  1.8.1 Global Non-Invasive Prenatal DNA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Non-Invasive Prenatal DNA Testing Service Market Size by Region, (2021-2032)
  1.8.3 North America Non-Invasive Prenatal DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.4 Europe Non-Invasive Prenatal DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.6 South America Non-Invasive Prenatal DNA Testing Service Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Natera
  2.1.1 Natera Details
  2.1.2 Natera Major Business
  2.1.3 Natera Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.1.4 Natera Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Natera Recent Developments and Future Plans
2.2 Labcorp
  2.2.1 Labcorp Details
  2.2.2 Labcorp Major Business
  2.2.3 Labcorp Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.2.4 Labcorp Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Labcorp Recent Developments and Future Plans
2.3 Quest Diagnostics
  2.3.1 Quest Diagnostics Details
  2.3.2 Quest Diagnostics Major Business
  2.3.3 Quest Diagnostics Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.3.4 Quest Diagnostics Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 MedGenome
  2.4.1 MedGenome Details
  2.4.2 MedGenome Major Business
  2.4.3 MedGenome Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.4.4 MedGenome Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 MedGenome Recent Developments and Future Plans
2.5 Mayo Clinic Laboratories
  2.5.1 Mayo Clinic Laboratories Details
  2.5.2 Mayo Clinic Laboratories Major Business
  2.5.3 Mayo Clinic Laboratories Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.5.4 Mayo Clinic Laboratories Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.6 SYNLAB
  2.6.1 SYNLAB Details
  2.6.2 SYNLAB Major Business
  2.6.3 SYNLAB Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.6.4 SYNLAB Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 SYNLAB Recent Developments and Future Plans
2.7 Myriad Genetics
  2.7.1 Myriad Genetics Details
  2.7.2 Myriad Genetics Major Business
  2.7.3 Myriad Genetics Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.7.4 Myriad Genetics Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 GGA
  2.8.1 GGA Details
  2.8.2 GGA Major Business
  2.8.3 GGA Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.8.4 GGA Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 GGA Recent Developments and Future Plans
2.9 Fulgent Genetics
  2.9.1 Fulgent Genetics Details
  2.9.2 Fulgent Genetics Major Business
  2.9.3 Fulgent Genetics Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.9.4 Fulgent Genetics Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Fulgent Genetics Recent Developments and Future Plans
2.10 BillionToOne
  2.10.1 BillionToOne Details
  2.10.2 BillionToOne Major Business
  2.10.3 BillionToOne Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.10.4 BillionToOne Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 BillionToOne Recent Developments and Future Plans
2.11 BGI Genomics
  2.11.1 BGI Genomics Details
  2.11.2 BGI Genomics Major Business
  2.11.3 BGI Genomics Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.11.4 BGI Genomics Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 BGI Genomics Recent Developments and Future Plans
2.12 Berry Genomics
  2.12.1 Berry Genomics Details
  2.12.2 Berry Genomics Major Business
  2.12.3 Berry Genomics Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.12.4 Berry Genomics Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Berry Genomics Recent Developments and Future Plans
2.13 Annaroad
  2.13.1 Annaroad Details
  2.13.2 Annaroad Major Business
  2.13.3 Annaroad Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.13.4 Annaroad Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Annaroad Recent Developments and Future Plans
2.14 Genesky
  2.14.1 Genesky Details
  2.14.2 Genesky Major Business
  2.14.3 Genesky Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.14.4 Genesky Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 Genesky Recent Developments and Future Plans
2.15 Weihansi Biomedical Technology
  2.15.1 Weihansi Biomedical Technology Details
  2.15.2 Weihansi Biomedical Technology Major Business
  2.15.3 Weihansi Biomedical Technology Non-Invasive Prenatal DNA Testing Service Product and Solutions
  2.15.4 Weihansi Biomedical Technology Non-Invasive Prenatal DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Weihansi Biomedical Technology Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Non-Invasive Prenatal DNA Testing Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Non-Invasive Prenatal DNA Testing Service by Company Revenue
  3.2.2 Top 3 Non-Invasive Prenatal DNA Testing Service Players Market Share in 2025
  3.2.3 Top 6 Non-Invasive Prenatal DNA Testing Service Players Market Share in 2025
3.3 Non-Invasive Prenatal DNA Testing Service Market: Overall Company Footprint Analysis
  3.3.1 Non-Invasive Prenatal DNA Testing Service Market: Region Footprint
  3.3.2 Non-Invasive Prenatal DNA Testing Service Market: Company Product Type Footprint
  3.3.3 Non-Invasive Prenatal DNA Testing Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Non-Invasive Prenatal DNA Testing Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Non-Invasive Prenatal DNA Testing Service Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Non-Invasive Prenatal DNA Testing Service Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2032)
6.2 North America Non-Invasive Prenatal DNA Testing Service Market Size by Application (2021-2032)
6.3 North America Non-Invasive Prenatal DNA Testing Service Market Size by Country
  6.3.1 North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2032)
  6.3.2 United States Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  6.3.3 Canada Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  6.3.4 Mexico Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2032)
7.2 Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2032)
7.3 Europe Non-Invasive Prenatal DNA Testing Service Market Size by Country
  7.3.1 Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2032)
  7.3.2 Germany Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.3 France Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.5 Russia Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  7.3.6 Italy Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market Size by Region
  8.3.1 Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Region (2021-2032)
  8.3.2 China Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.3 Japan Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.4 South Korea Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.5 India Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  8.3.7 Australia Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2032)
9.2 South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2032)
9.3 South America Non-Invasive Prenatal DNA Testing Service Market Size by Country
  9.3.1 South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2032)
  9.3.2 Brazil Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  9.3.3 Argentina Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market Size by Country
  10.3.1 Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2032)
  10.3.2 Turkey Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)
  10.3.4 UAE Non-Invasive Prenatal DNA Testing Service Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Non-Invasive Prenatal DNA Testing Service Market Drivers
11.2 Non-Invasive Prenatal DNA Testing Service Market Restraints
11.3 Non-Invasive Prenatal DNA Testing Service Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Non-Invasive Prenatal DNA Testing Service Industry Chain
12.2 Non-Invasive Prenatal DNA Testing Service Upstream Analysis
12.3 Non-Invasive Prenatal DNA Testing Service Midstream Analysis
12.4 Non-Invasive Prenatal DNA Testing Service Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer


LIST OF TABLES

Table 1. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Table 3. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Natera Company Information, Head Office, and Major Competitors
Table 8. Natera Major Business
Table 9. Natera Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 10. Natera Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Natera Recent Developments and Future Plans
Table 12. Labcorp Company Information, Head Office, and Major Competitors
Table 13. Labcorp Major Business
Table 14. Labcorp Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 15. Labcorp Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Labcorp Recent Developments and Future Plans
Table 17. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 18. Quest Diagnostics Major Business
Table 19. Quest Diagnostics Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 20. Quest Diagnostics Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. MedGenome Company Information, Head Office, and Major Competitors
Table 22. MedGenome Major Business
Table 23. MedGenome Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 24. MedGenome Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. MedGenome Recent Developments and Future Plans
Table 26. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 27. Mayo Clinic Laboratories Major Business
Table 28. Mayo Clinic Laboratories Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 29. Mayo Clinic Laboratories Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 31. SYNLAB Company Information, Head Office, and Major Competitors
Table 32. SYNLAB Major Business
Table 33. SYNLAB Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 34. SYNLAB Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. SYNLAB Recent Developments and Future Plans
Table 36. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 37. Myriad Genetics Major Business
Table 38. Myriad Genetics Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 39. Myriad Genetics Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Myriad Genetics Recent Developments and Future Plans
Table 41. GGA Company Information, Head Office, and Major Competitors
Table 42. GGA Major Business
Table 43. GGA Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 44. GGA Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. GGA Recent Developments and Future Plans
Table 46. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 47. Fulgent Genetics Major Business
Table 48. Fulgent Genetics Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 49. Fulgent Genetics Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Fulgent Genetics Recent Developments and Future Plans
Table 51. BillionToOne Company Information, Head Office, and Major Competitors
Table 52. BillionToOne Major Business
Table 53. BillionToOne Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 54. BillionToOne Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. BillionToOne Recent Developments and Future Plans
Table 56. BGI Genomics Company Information, Head Office, and Major Competitors
Table 57. BGI Genomics Major Business
Table 58. BGI Genomics Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 59. BGI Genomics Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. BGI Genomics Recent Developments and Future Plans
Table 61. Berry Genomics Company Information, Head Office, and Major Competitors
Table 62. Berry Genomics Major Business
Table 63. Berry Genomics Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 64. Berry Genomics Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Berry Genomics Recent Developments and Future Plans
Table 66. Annaroad Company Information, Head Office, and Major Competitors
Table 67. Annaroad Major Business
Table 68. Annaroad Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 69. Annaroad Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Annaroad Recent Developments and Future Plans
Table 71. Genesky Company Information, Head Office, and Major Competitors
Table 72. Genesky Major Business
Table 73. Genesky Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 74. Genesky Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Genesky Recent Developments and Future Plans
Table 76. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 77. Weihansi Biomedical Technology Major Business
Table 78. Weihansi Biomedical Technology Non-Invasive Prenatal DNA Testing Service Product and Solutions
Table 79. Weihansi Biomedical Technology Non-Invasive Prenatal DNA Testing Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 81. Global Non-Invasive Prenatal DNA Testing Service Revenue (USD Million) by Players (2021-2026)
Table 82. Global Non-Invasive Prenatal DNA Testing Service Revenue Share by Players (2021-2026)
Table 83. Breakdown of Non-Invasive Prenatal DNA Testing Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 84. Market Position of Players in Non-Invasive Prenatal DNA Testing Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 85. Head Office of Key Non-Invasive Prenatal DNA Testing Service Players
Table 86. Non-Invasive Prenatal DNA Testing Service Market: Company Product Type Footprint
Table 87. Non-Invasive Prenatal DNA Testing Service Market: Company Product Application Footprint
Table 88. Non-Invasive Prenatal DNA Testing Service New Market Entrants and Barriers to Market Entry
Table 89. Non-Invasive Prenatal DNA Testing Service Mergers, Acquisition, Agreements, and Collaborations
Table 90. Global Non-Invasive Prenatal DNA Testing Service Consumption Value (USD Million) by Type (2021-2026)
Table 91. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Share by Type (2021-2026)
Table 92. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Forecast by Type (2027-2032)
Table 93. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026)
Table 94. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Forecast by Application (2027-2032)
Table 95. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 96. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 97. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 98. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 99. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 100. North America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 101. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 104. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 105. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 106. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 107. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 108. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 109. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value by Region (2027-2032) & (USD Million)
Table 113. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 114. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 115. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 116. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 117. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 118. South America Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2021-2026) & (USD Million)
Table 120. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Type (2027-2032) & (USD Million)
Table 121. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2021-2026) & (USD Million)
Table 122. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Application (2027-2032) & (USD Million)
Table 123. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value by Country (2027-2032) & (USD Million)
Table 125. Global Key Players of Non-Invasive Prenatal DNA Testing Service Upstream (Raw Materials)
Table 126. Global Non-Invasive Prenatal DNA Testing Service Typical Customers

LIST OF FIGURES

Figure 1. Non-Invasive Prenatal DNA Testing Service Picture
Figure 2. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type in 2025
Figure 4. Core Condition Screening
Figure 5. Expanded Condition Screening
Figure 6. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Sequencing Method, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Sequencing Method in 2025
Figure 8. Whole Genome Sequencing
Figure 9. Targeted Sequencing
Figure 10. Others
Figure 11. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Service Model in 2025
Figure 13. Public Health Program
Figure 14. Consumer
Figure 15. Others
Figure 16. Global Non-Invasive Prenatal DNA Testing Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application in 2025
Figure 18. Public Hospitals Picture
Figure 19. Private Hospitals Picture
Figure 20. Global Non-Invasive Prenatal DNA Testing Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Non-Invasive Prenatal DNA Testing Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Market Non-Invasive Prenatal DNA Testing Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 23. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Region (2021-2032)
Figure 24. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Region in 2025
Figure 25. North America Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Company Three Recent Developments and Future Plans
Figure 31. Global Non-Invasive Prenatal DNA Testing Service Revenue Share by Players in 2025
Figure 32. Non-Invasive Prenatal DNA Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 33. Market Share of Non-Invasive Prenatal DNA Testing Service by Player Revenue in 2025
Figure 34. Top 3 Non-Invasive Prenatal DNA Testing Service Players Market Share in 2025
Figure 35. Top 6 Non-Invasive Prenatal DNA Testing Service Players Market Share in 2025
Figure 36. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Share by Type (2021-2026)
Figure 37. Global Non-Invasive Prenatal DNA Testing Service Market Share Forecast by Type (2027-2032)
Figure 38. Global Non-Invasive Prenatal DNA Testing Service Consumption Value Share by Application (2021-2026)
Figure 39. Global Non-Invasive Prenatal DNA Testing Service Market Share Forecast by Application (2027-2032)
Figure 40. North America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 41. North America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 42. North America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 43. United States Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 44. Canada Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 45. Mexico Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 46. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 47. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 48. Europe Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 50. France Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Region (2021-2032)
Figure 57. China Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 58. Japan Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 59. South Korea Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 60. India Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Southeast Asia Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 62. Australia Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 63. South America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 64. South America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 65. South America Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Non-Invasive Prenatal DNA Testing Service Consumption Value Market Share by Country (2021-2032)
Figure 71. Turkey Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 73. UAE Non-Invasive Prenatal DNA Testing Service Consumption Value (2021-2032) & (USD Million)
Figure 74. Non-Invasive Prenatal DNA Testing Service Market Drivers
Figure 75. Non-Invasive Prenatal DNA Testing Service Market Restraints
Figure 76. Non-Invasive Prenatal DNA Testing Service Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Non-Invasive Prenatal DNA Testing Service Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source


More Publications